XML 57 R44.htm IDEA: XBRL DOCUMENT v3.25.0.1
Common Stock and Share-Based Compensation (Tables)
12 Months Ended
Dec. 28, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Options under Equity Plan and Non-Employee Director Plan

Information related to stock options under the Equity Plan and the Non-Employee Director Plan is summarized as follows:

 

 

 

Shares

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term in Years

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 30, 2023

 

 

207,810

 

 

$

361.53

 

 

 

 

 

 

 

Granted

 

 

25,635

 

 

 

299.57

 

 

 

 

 

 

 

Exercised

 

 

(8,164

)

 

 

203.68

 

 

 

 

 

 

 

Cancelled/Forfeited

 

 

(15,487

)

 

 

383.46

 

 

 

 

 

 

 

Expired

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Outstanding at December 28, 2024

 

 

209,794

 

 

$

358.48

 

 

 

4.93

 

 

$

5,913

 

Exercisable at December 28, 2024

 

 

126,930

 

 

$

328.56

 

 

 

3.91

 

 

$

5,611

 

Vested and expected to vest at December 28, 2024

 

 

200,272

 

 

$

360.37

 

 

 

4.77

 

 

$

5,865

 

 

Stock-Based Compensation Expense Included in Operating Expenses

The following table provides information regarding stock-based compensation expense included in operating expenses in the accompanying consolidated statements of comprehensive income:

 

 

 

2024

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Amounts included in general and administrative
   expenses

 

$

11,835

 

 

$

10,370

 

 

$

8,804

 

Amounts included in advertising, promotional, and
   selling expenses

 

 

7,119

 

 

 

6,601

 

 

 

5,184

 

Total stock-based compensation expense

 

$

18,954

 

 

$

16,971

 

 

$

13,988

 

Amounts related to performance-based stock awards
   included in total stock-based compensation expense

 

$

2,720

 

 

$

2,518

 

 

$

1,198

 

 

Weighted Average Assumptions used to Estimate Fair Value of Stock Options

Weighted average assumptions used to estimate fair values of stock options on the date of grants for fiscal 2024, 2023, and 2022 was as follows:

 

 

 

2024

 

 

2023

 

 

2022

 

Expected volatility

 

 

40.0

%

 

 

39.7

%

 

 

38.0

%

Risk-free interest rate

 

 

4.23

%

 

 

3.96

%

 

 

2.11

%

Expected dividends

 

 

0

%

 

 

0

%

 

 

0

%

Exercise factor

 

2.1 times

 

 

2.3 times

 

 

3.0 times

 

Discount for post-vesting restrictions

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

Summary of Vesting Activities of Shares Issued Under Investment Share Program and Restricted Stock Awards

The following table summarizes vesting activities of shares issued under the investment share program and restricted stock awards:

 

 

 

Number of Shares

 

 

Weighted Average Fair Value

 

Non-vested at December 30, 2023

 

 

114,797

 

 

$

373.56

 

Granted

 

 

88,266

 

 

 

290.71

 

Vested

 

 

(32,823

)

 

 

381.95

 

Forfeited

 

 

(5,689

)

 

 

331.93

 

Non-vested at December 28, 2024

 

 

164,551

 

 

$

328.88